Qindong Guo
Overview
Explore the profile of Qindong Guo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
721
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yin X, Guo Q, Ji X, Li X, Xue H, Xin Q, et al.
Biosens Bioelectron
. 2025 Feb;
277:117291.
PMID: 39999610
MicroRNAs have started being used as an effective marker in early diagnosis and preoperative monitoring of cancers in recent years. Traditional microRNA testing technology, such as quantitative reverse transcription polymerase...
2.
Zhao S, Zhao R, Wang C, Ma C, Gao Z, Li B, et al.
Theranostics
. 2024 Dec;
14(18):7072-7087.
PMID: 39629136
Glioblastoma multiforme (GBM) is an aggressive brain tumour for which current traditional treatment approaches have been unsuccessful, owing to the high genetic heterogeneity and immunosuppressive tumour microenvironment. Single-cell and spatial...
3.
Qiu J, Guo Q, Chu Y, Wang C, Xue H, Zhang Y, et al.
Anal Chim Acta
. 2024 Apr;
1304:342576.
PMID: 38637043
Background: Small endosome-derived lipid nanovesicles (30-200 nm) are actively secreted by living cells and serve as pivotal biomarkers for early cancer diagnosis. However, the study of extracellular vesicles (EVs) requires...
4.
Qiu W, Guo Q, Guo X, Wang C, Li B, Qi Y, et al.
J Nanobiotechnology
. 2023 Jul;
21(1):233.
PMID: 37481646
Background: The immunosuppressive microenvironment in glioma induces immunotherapy resistance and is associated with poor prognosis. Glioma-associated mesenchymal stem cells (GA-MSCs) play an important role in the formation of the immunosuppressive...
5.
Fan Y, Gao Z, Xu J, Wang H, Guo Q, Li B, et al.
Theranostics
. 2023 Jun;
13(10):3310-3329.
PMID: 37351164
Glioma stem cells (GSCs) are a key factor in glioblastoma (GBM) development and treatment resistance. GSCs can be divided into the mesenchymal (MES) and proneural (PN) subtypes, and these two...
6.
Guo Q, Fan Y, Wang Q, Li B, Qiu W, Qi Y, et al.
Cell Death Dis
. 2023 Feb;
14(2):147.
PMID: 36810326
Glioma is the most common malignant tumor of the central nervous system in adults. The tumor microenvironment (TME) is related to poor prognosis in glioma patients. Glioma cells could sort...
7.
Zhao S, Li B, Zhao R, Pan Z, Zhang S, Qiu W, et al.
Oncogene
. 2022 Nov;
42(2):138-153.
PMID: 36396726
Circular RNAs (circRNAs) play important roles in the malignant progression of tumours. Herein, we identified an unreported circRNA (hsa-circ-0072688, also named circADAMTS6) that is specifically upregulated in the hypoxic microenvironment...
8.
The N-methyladenosine-mediated lncRNA WEE2-AS1 promotes glioblastoma progression by stabilizing RPN2
Li B, Zhao R, Qiu W, Pan Z, Zhao S, Qi Y, et al.
Theranostics
. 2022 Sep;
12(14):6363-6379.
PMID: 36168628
Glioblastoma (GBM) is the most common primary brain malignancy and has high aggressiveness and a poor prognosis. N6-methyladenosine (m6A) represents the most prevalent methylation modification of lncRNAs and has been...
9.
Fan Y, Gao Z, Xu J, Wang H, Guo Q, Xue H, et al.
Front Immunol
. 2022 Sep;
13:986615.
PMID: 36159816
Glioblastoma (GBM) patients exhibit high mortality and recurrence rates despite multimodal therapy. Small nucleolar RNA host genes (SNHGs) are a group of long noncoding RNAs that perform a wide range...
10.
Li B, Chen X, Qiu W, Zhao R, Duan J, Zhang S, et al.
Adv Sci (Weinh)
. 2022 May;
9(17):e2105451.
PMID: 35508804
Glioblastoma (GBM) is one of the most fatal central nervous system tumors and lacks effective or sufficient therapies. Ferroptosis is a newly discovered method of programmed cell death and opens...